%0 eBook %M Solr-EB001853606 %A McDonagh, Marian S. %I Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services %D 2017 %C Rockville, MD %G English %B AHRQ publication %T Treatments for schizophrenia in adults : a systematic review %U https://www.ncbi.nlm.nih.gov/books/NBK487628 %X CONCLUSIONS: Most comparative evidence on pharmacotherapy relates to the older drugs, with clozapine, olanzapine, and risperidone superior on more outcomes than other SGAs. Older SGAs were similar to haloperidol on benefit outcomes but had fewer adverse event outcomes. Most psychosocial interventions improved functional outcomes, quality of life, and core illness symptoms, and several reduced relapse compared with usual care